GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 98 filers reported holding GOSSAMER BIO INC in Q1 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $279,260 | -70.7% | 309,979 | -61.7% | 0.00% | -50.0% |
Q1 2024 | $954,350 | +2.3% | 808,771 | -20.9% | 0.00% | 0.0% |
Q4 2023 | $932,813 | +108.9% | 1,022,261 | +90.7% | 0.00% | +100.0% |
Q3 2023 | $446,460 | -76.3% | 536,095 | -65.8% | 0.00% | -80.0% |
Q2 2023 | $1,883,242 | -20.3% | 1,569,368 | -16.3% | 0.01% | -28.6% |
Q1 2023 | $2,362,902 | -25.6% | 1,875,319 | +28.2% | 0.01% | -30.0% |
Q4 2022 | $3,174,970 | -71.4% | 1,463,120 | +58.1% | 0.01% | -73.7% |
Q3 2022 | $11,090,000 | +439.7% | 925,727 | +277.0% | 0.04% | +442.9% |
Q2 2022 | $2,055,000 | -47.3% | 245,560 | -45.3% | 0.01% | -41.7% |
Q1 2022 | $3,898,000 | +3.7% | 449,057 | +35.2% | 0.01% | +50.0% |
Q4 2021 | $3,758,000 | +57.9% | 332,251 | +75.5% | 0.01% | +60.0% |
Q3 2021 | $2,380,000 | -38.7% | 189,360 | -60.4% | 0.01% | -44.4% |
Q2 2021 | $3,882,000 | -39.9% | 478,060 | -31.5% | 0.01% | -47.1% |
Q1 2021 | $6,457,000 | +295.4% | 698,075 | +313.4% | 0.02% | +240.0% |
Q4 2020 | $1,633,000 | -63.2% | 168,855 | -52.8% | 0.01% | -68.8% |
Q3 2020 | $4,437,000 | +16.5% | 357,563 | +22.0% | 0.02% | -15.8% |
Q2 2020 | $3,809,000 | +1265.2% | 293,019 | +966.8% | 0.02% | +850.0% |
Q1 2020 | $279,000 | – | 27,466 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 3,320,608 | $41,740,000 | 4.68% |
Octagon Capital Advisors LP | 1,513,138 | $19,020,000 | 4.68% |
Ally Bridge Group (NY) LLC | 1,175,000 | $14,770,000 | 4.34% |
Parkman Healthcare Partners LLC | 786,870 | $9,891,000 | 2.50% |
Palo Alto Investors LP | 1,772,950 | $22,286,000 | 1.34% |
HHLR ADVISORS, LTD. | 7,420,974 | $93,282,000 | 1.22% |
Ikarian Capital, LLC | 1,351,933 | $16,995,000 | 1.20% |
Boxer Capital, LLC | 2,462,358 | $30,952,000 | 1.08% |
ACUTA CAPITAL PARTNERS, LLC | 215,000 | $2,703,000 | 0.95% |
EMERALD ADVISERS, LLC | 1,516,003 | $19,056,000 | 0.69% |